Macular Telangiectasia Type 2 (MacTel)

Schedule Today
How Rare Is MacTel?
MacTel is uncommon, affecting about 5 to 10 in every 10,000 people over age 40. Because symptoms often start slowly, the condition may be underdiagnosed without special eye imaging.
Yes, MacTel usually affects both eyes, though one eye may be more affected than the other. Even if only one eye has symptoms now, both eyes should be monitored over time.
What Are the Different Types?
There are several types of macular telangiectasia, but type 2 is by far the most common form we see in adults. Type 1 usually affects only one eye and is often linked to other eye problems. Other types are extremely rare.
Causes and Risk Factors
The exact cause of MacTel is not fully understood, but researchers believe it involves complex changes in the retina. The disease is not contagious and appears to develop on its own in most people.
While no single MacTel gene has been found, there can be a family tendency. Some families have more than one person with MacTel, but most cases occur in people with no family history of the disease.
MacTel usually appears in people aged 50–70, but it can happen earlier. The risk rises with age, likely because of long-term changes in the retina over time.
MacTel is considered an isolated eye condition. While some people with MacTel may have other health conditions, there is no proven link showing that diabetes, high blood pressure, or other diseases cause MacTel.
Currently, no specific lifestyle factors have been proven to cause MacTel. Research continues to look at possible influences, but the disease appears to develop naturally in susceptible people.
Diagnosis and Testing
MacTel requires a careful eye exam and special imaging tests to diagnose and track the disease. These tests help your doctor see changes that may not be visible during a regular eye exam.
Your doctor will use a special lens to look at your retina. They’ll check for subtle gray areas, telangiectatic blood vessels, and areas where pigment may migrate.
OCT takes detailed, cross-section pictures of your retina, showing if the light-sensing cells are thinning or if there are cavities in the retina.
A special dye is injected into your arm and photographed as it travels through your eye to show abnormal blood vessels. While generally safe, there is a small risk of allergic reaction or side effects.
This test maps the health of the retina using natural fluorescence, showing areas where the retina is changing.
These tests map out blind spots in your vision, even before you notice them. They help show how MacTel is affecting your daily life.
Special tests check how well you can see colors and contrasts, which may show problems before standard eye charts do.
Stages of MacTel
MacTel progression is usually described as early, intermediate, or advanced disease based on eye exam and imaging findings. Not everyone progresses through all stages, and the timeline can be different for each person.
Your retina may look nearly normal during regular examination, but imaging can show the earliest changes. You may have few or no symptoms at this stage.
The retina may look grayish, and blood vessels start to change. You may begin to notice difficulty reading and seeing details.
Abnormal blood vessels and more retinal thinning can develop, and dark pigment clumping may appear. Reading and detailed vision become much harder.
In some people, new, fragile blood vessels grow beneath the retina. This can cause sudden vision changes if not treated and requires immediate attention.
Treatment and Management
There is no cure for MacTel. Care focuses on regular monitoring, treating complications, and supporting your vision with rehabilitation and technology.
This is the first FDA-approved treatment for MacTel. A tiny implanted device slowly releases a protective protein to help slow the loss of photoreceptors; it does not restore lost vision and is not a cure.
If new blood vessels develop, special injections can help control leakage and swelling to protect vision. These medications include bevacizumab, ranibizumab, and aflibercept.
There is no strong evidence that vitamins or supplements slow MacTel progression. Standard eye vitamins like the AREDS formulation are not recommended specifically for MacTel.
Maintaining good overall health with regular medical care supports overall well-being, though it has not been proven to slow MacTel progression.
Ongoing research may offer access to new treatments or monitoring strategies. Ask your doctor if you might qualify for current studies.
Living with MacTel (Low Vision Support)
Most people with MacTel can stay independent with help from low vision aids, rehabilitation, and thoughtful lifestyle changes. Support and training can make a significant difference in daily life.
Specialists can teach you how to use your remaining vision best, such as looking slightly off-center to see around blind spots. This training is called eccentric viewing.
There are many tools to help with daily tasks:
- Electronic magnifiers and CCTV reading systems
- Smartphone apps that read text aloud or identify objects
- Large print and high-contrast materials
- Voice-activated smart home devices
- Special lighting for reading and close work
Good lighting, reducing clutter, and using high-contrast markers can make daily tasks easier and safer. Simple changes can preserve independence.
Support groups and counseling can help with coping and connect you with others facing similar challenges. Many people find this connection very helpful.
Your Care With Us
Retina Consultants offers expert care for MacTel, from advanced imaging and FDA-approved treatment options to comprehensive support and rehabilitation, to help protect vision and quality of life.
